Zevra Therapeutics, Inc.
2021 Q2 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 1,618 | 0.0% | 180,618 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 1,500 | 0.0% | 157,765 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 1,427 | 0.0% | 161,967 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 1,148 | 0.0% | 153,331 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 1,247 | 0.0% | 149,504 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 842 | 0.0% | 121,356 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 541 | 0.0% | 110,318 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 530 | 0.0% | 91,410 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 630 | 0.0% | 96,130 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 436 | 0.0% | 90,432 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 461 | 0.0% | 90,432 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 61 | 0.0% | 11,139 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 51 | 0.0% | 11,139 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 70 | 0.0% | 11,139 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 50 | 0.0% | 11,139 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 384 | 0.0% | 76,237 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 665 | 0.0% | 76,237 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 670 | 0.0% | 71,732 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 920 | 0.0% | 71,732 | 6/30/2021 |